Capricor Therapeutics Competitors and Similar CompaniesClear all

Capricor Therapeutics's competitors and similar companies include Keros Therapeutics, 19Labs, Stuart Therapeutics and LyGenesis.
Capricor Therapeutics
Capricor Therapeutics
Capricor Therapeutics is a biotechnology company focused on the discovery, development & commercialization of first-in-class therapeutics for the treatment of diseases.
Keros Therapeutics
Keros Therapeutics
Keros Therapeutics is a biotechnology company dedicated to the discovery and development of therapeutics for hematological and musculoskeletal disorders.
19Labs
19Labs
19Labs provides healthcare solutions.
Stuart Therapeutics
Stuart Therapeutics
Stuart Therapeutics is a biotechnology company that develops a tissue reparative platform for eye diseases.
LyGenesis
LyGenesis
LyGenesis is a biotechnology company with an organ regeneration technology platform enabling a patient’s lymph nodes to be used as bioreactors to regrow functioning ectopic organs.
Founding Date
Founding Date
2005
Founding Date
2015
Founding Date
2015
Founding Date
2018
Founding Date
2017
Type
Type
Public
Type
Public
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Beverly Hills, US HQ
Locations
Lexington, US HQ
Locations
San Mateo, US HQ
Brentwood Bay, CA
Locations
Stuart, US HQ
Locations
Pittsburgh, US HQ
Pittsburgh, US
Employees
Employees
1854% decrease
Employees
23
Employees
129% increase
Employees
8
Employees
5
Valuation ($)
Valuation ($)
147.4 m
Valuation ($)
952.8 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Twitter followers
Twitter followers
7
Twitter followers
N/A
Twitter followers
252
Twitter followers
N/A
Twitter followers
N/A
Employee Rating
Employee Rating
2.1
Employee Rating
2
Employee Rating
3.5
Employee Rating
N/A
Employee Rating
N/A

Financial

Net income
Net income
($29m) (FY, 2022)
Net income
($104.7m) (FY, 2022)
Net income
N/A
Net income
N/A
Net income
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 11m (over 2 years ago)
Latest funding round
$ 4m (almost 4 years ago)
Total funding raised
Total funding raised
$ 78.5m
Total funding raised
$ 90m
Total funding raised
N/A
Total funding raised
$ 11m
Total funding raised
$ 7m
For sources of this data, please see the company profile

View Company Profiles

Keros Therapeutics
HQ
Lexington, US
Employees
23

Keros Therapeutics is a biotechnology company dedicated to the discovery and development of therapeutics for hematological and musculoskeletal disorders.

View company
19Labs
HQ
San Mateo, US
Employees
12↑ 9% increase

19Labs provides healthcare solutions.

View company
Stuart Therapeutics
HQ
Stuart, US
Employees
8

Stuart Therapeutics is a biotechnology company that develops a tissue reparative platform for eye diseases.

View company
LyGenesis
HQ
Pittsburgh, US
Employees
5

LyGenesis is a biotechnology company with an organ regeneration technology platform enabling a patient’s lymph nodes to be used as bioreactors to regrow functioning ectopic organs.

View company